Archive
Page 6 of 10. Search and filter the full archive.
Markets15th July 2026
South Korea's shipping cartel ran for 15 years across three major trade routes. The case is a textbook study in how cartels form, how they enforce discipline, and why concentrated industries make collusion so hard to prevent.
Jay Patel9 min read
Private Equity13th July 2026
Apollo has gatecrashed Castlelake's hard-won takeover of easyJet with a higher offer backed by the airline's board, setting up a bidding war over one of Europe's best-known low-cost carriers just months after a bruising first half of the year.
Sonal Weerasekera7 min read
Macro10th July 2026
The Iran war sent oil prices soaring and hit every major economy at once, yet the Fed, the Bank of England, and the European Central Bank all responded differently. The divergence turned not on the shock itself but on each bank's headroom, growth outlook, and framework for interpreting supply-driven inflation.
Kaveesha Maddala4 min read
MarketsGlobal Healthcare10th July 2026
Vertex's $10 billion acquisition of Crinetics is about far more than adding another drug to its portfolio. It is a strategic bet on an endocrinology platform that could fuel the company's next phase of growth.
Abdul Wasey Bhatti6 min read
The Bank of Japan has raised its policy rate five times since 2024, yet the yen just hit a forty year low. Here is what two years of tightening have actually changed, and what is likely to happen next.
Rohan Talwar13 min read
MarketsPrivate Equity6th July 2026
A £5.7bn approach for DCC is as much a bet on the Irish conglomerate's years-long transformation into an energy distributor as it is a straightforward take-private deal, and it says as much about KKR's ambitions as it does about DCC itself.
Sonal Weerasekera7 min read
MarketsPrivate Equity3rd July 2026
From preferred equity deals for LP stakes to carried interest loans for executives, private equity is manufacturing liquidity at every level of the food chain. The exit market remains blocked. The workarounds are getting bigger.
Alexander Eklund7 min read
MarketsGlobal Healthcare3rd July 2026
As NHS waiting lists for autism assessments pass 200,000, private capital is flowing into neurodiversity services – forcing the question of whether profit and patient care can ever be aligned.
Abdul Wasey Bhatti8 min read
From rocketing IPOs to frothy market sentiment, at face value, today’s AI trade unmistakably mirrors the dot-com bubble – only this time the fallout could be far more destructive.
Martim Domingos7 min read
MarketsPrivate Credit29th June 2026
Pimco, the $2.3tn bond giant built on public markets, is quietly becoming one of the most powerful actors in private credit with mega-deals for Meta and Oracle, lending to Gulf states in wartime, and exploiting the liquidity crunch hitting rival funds.
Sonal Weerasekera10 min read
MarketsGlobal Healthcare26th June 2026
A single FDA reversal sent Regenxbio's shares soaring and reignited optimism across gene therapy - but one favourable decision cannot solve the commercial challenges that pushed the industry into crisis.
Abdul Wasey Bhatti6 min read
The DOJ says criminal charges are now on the table for firms that use algorithms to coordinate prices. The question at the heart of the case is whether software can produce cartel-like outcomes without anyone picking up a phone.
Jay Patel10 min read